These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 23233628)

  • 1. Pharmacologic tools to reduce bleeding in surgery.
    Schulman S
    Hematology Am Soc Hematol Educ Program; 2012; 2012():517-21. PubMed ID: 23233628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic resuscitation in postpartum hemorrhage - a supplement to surgery.
    Ekelund K; Hanke G; Stensballe J; Wikkelsøe A; Albrechtsen CK; Afshari A
    Acta Obstet Gynecol Scand; 2015 Jul; 94(7):680-692. PubMed ID: 25660118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coagulopathy in liver disease: a balancing act.
    Kujovich JL
    Hematology Am Soc Hematol Educ Program; 2015; 2015():243-9. PubMed ID: 26637729
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of two doses of tranexamic acid on fibrinolysis evaluated by thromboelastography during cardiac surgery: a randomised, controlled study.
    Faraoni D; Cacheux C; Van Aelbrouck C; Ickx BE; Barvais L; Levy JH
    Eur J Anaesthesiol; 2014 Sep; 31(9):491-8. PubMed ID: 24557022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel pharmacologic approaches to reduce bleeding.
    Levy JH
    Can J Anaesth; 2003; 50(6 Suppl):S26-30. PubMed ID: 14629050
    [No Abstract]   [Full Text] [Related]  

  • 6. Monitoring prohemostatic treatment in bleeding patients.
    Ranucci M; Baryshnikova E; Colella D
    Semin Thromb Hemost; 2012 Apr; 38(3):282-91. PubMed ID: 22510861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tranexamic acid, fibrinogen concentrate, and prothrombin complex concentrate: data to support prehospital use?
    Schöchl H; Schlimp CJ; Maegele M
    Shock; 2014 May; 41 Suppl 1():44-6. PubMed ID: 24296431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does tranexamic acid reduce desmopressin-induced hyperfibrinolysis?
    Ozal E; Kuralay E; Bingöl H; Cingöz F; Ceylan S; Tatar H
    J Thorac Cardiovasc Surg; 2002 Mar; 123(3):539-43. PubMed ID: 11882828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleeding and management of coagulopathy.
    Sniecinski RM; Levy JH
    J Thorac Cardiovasc Surg; 2011 Sep; 142(3):662-7. PubMed ID: 21549397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
    Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
    Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of thromboelastometry in the assessment of hemostasis during orthotopic liver transplantation reduces the demand for blood products.
    Trzebicki J; Flakiewicz E; Kosieradzki M; Blaszczyk B; Kołacz M; Jureczko L; Pacholczyk M; Chmura A; Lagiewska B; Lisik W; Wasiak D; Kosson D; Kwiatkowski A; Lazowski T
    Ann Transplant; 2010; 15(3):19-24. PubMed ID: 20877262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Living without aprotinin: the results of a 5-year blood saving program in cardiac surgery.
    Ranucci M; Castelvecchio S; Romitti F; Isgrò G; Ballotta A; Conti D
    Acta Anaesthesiol Scand; 2009 May; 53(5):573-80. PubMed ID: 19173686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunct agents for bleeding.
    Franchini M; Mannucci PM
    Curr Opin Hematol; 2014 Nov; 21(6):503-8. PubMed ID: 25159711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of tourniquet application, tranexamic acid, and desmopressin on the procoagulant and fibrinolytic systems during total knee replacement.
    Ellis MH; Fredman B; Zohar E; Ifrach N; Jedeikin R
    J Clin Anesth; 2001 Nov; 13(7):509-13. PubMed ID: 11704449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin and low-molecular-weight heparin: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
    Hirsh J; Raschke R
    Chest; 2004 Sep; 126(3 Suppl):188S-203S. PubMed ID: 15383472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate effects of individualized heparin and protamine management on hemostatic activation and platelet function in adult patients undergoing cardiac surgery with tranexamic acid antifibrinolytic therapy.
    Hofmann B; Bushnaq H; Kraus FB; Raspé C; Simm A; Silber RE; Ludwig-Kraus B
    Perfusion; 2013 Sep; 28(5):412-8. PubMed ID: 23625867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential antidotes for reversal of old and new oral anticoagulants.
    Suryanarayan D; Schulman S
    Thromb Res; 2014 May; 133 Suppl 2():S158-66. PubMed ID: 24862137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bleeding in patients using new anticoagulants or antiplatelet agents: risk factors and management.
    Levi MM; Eerenberg E; Löwenberg E; Kamphuisen PW
    Neth J Med; 2010 Feb; 68(2):68-76. PubMed ID: 20167958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.